Role of Melatonin in Human Eye Physiology and Its Implications for Ophthalmic Diseases Treatment (Review)
Open Access
- 5 July 2021
- journal article
- Published by PE Polunina Elizareta Gennadievna in Ophthalmology in Russia
- Vol. 18 (2), 234-239
- https://doi.org/10.18008/1816-5095-2021-2-234-239
Abstract
Melatonin is a hormone of the epiphysis and a regulator of circadian rhythms of living organisms, which affects a number of important physiological processes. Melatonin synthesis has also been found in other organs, in particular in various structural systems of the eyeball. A number of studies demonstrate that melatonin plays an important role in a variety of biochemical and physiological processes that ensure functioning of visual analyzer. This review provides information on the synthesis of melatonin, its secretion and metabolism, considers key information about melatonin receptors (MT1, MT2 and MT3), their localization in various eye’s structures, and their affinity to melatonin. Over the last years, researchers’ attention has been drawn to the therapeutic properties of melatonin, relevant for treatment of age-related diseases. The aggressive effects of solar radiation and environmental toxicants expose the organ of vision to oxidative attacks. A large amount of evidence has been accumulated of the participation of oxidative stress in the development of many eye diseases, resulting in an imbalance between the generation of reactive oxygen species and the expression of antioxidant enzymes. Melatonin, which has antioxidant and anti-inflammatory properties and regulates mitochondrial functions, can be a powerful tool to counter age-related changes. Globally, the number of people of all ages with visual impairment is estimated at 285 million. Cataract and age-related macular degeneration (AMD) are the leading causes of vision loss around the world. AMD and cataracts often coexist in patients, so there is a concern that age-related cataract surgery increases the risk of morbidity and progression of AMD. The pathogenesis of both cataracts and AMD is still unclear, although a number of theories have been put forward, including oxidative stress, age-related changes, inflammatory processes, etc. Analysis of modern domestic and foreign literature shows good perspectives of using melatonin as preventive and therapeutic agent in the treatment of ophthalmic diseases of various origins.Keywords
This publication has 47 references indexed in Scilit:
- On the free radical scavenging activities of melatonin's metabolites, AFMK and AMKJournal of Pineal Research, 2012
- Age-Related Changes in the Daily Rhythm of Photoreceptor Functioning and Circuitry in a Melatonin-Proficient Mouse StrainPLOS ONE, 2012
- Melatonin membrane receptors in peripheral tissues: Distribution and functionsMolecular and Cellular Endocrinology, 2012
- Localization of Melatonin Receptor 1 in Mouse Retina and Its Role in the Circadian Regulation of the Electroretinogram and Dopamine LevelsPLOS ONE, 2011
- Interaction between Connexin50 and Mitogen-activated Protein Kinase Signaling in Lens HomeostasisMolecular Biology of the Cell, 2009
- Mitochondrial function and redox control in the aging eye: Role of MsrA and other repair systems in cataract and macular degenerationsExperimental Eye Research, 2009
- Oxidative damage–induced inflammation initiates age-related macular degenerationNature Medicine, 2008
- A continuous correlation between oxidative stress and telomere shortening in fibroblastsExperimental Gerontology, 2007
- Expression and cellular localization of melatonin‐synthesizing enzymes in the rat lensJournal of Pineal Research, 2006
- Organs from mice deleted for NRH:quinone oxidoreductase 2 are deprived of the melatonin binding site MT3FEBS Letters, 2004